Qualtec Co

Qualtec Co Net Change in Cash

The Net Change in Cash of Qualtec Co (9165.T) as of Oct 20, 2026 is 910.89 M JPY. In the previous year, Net Change in Cash was -367.77 M JPY — a change of -347.68% (higher).

Net Change in Cash

910.89 MJPY

YoY

-347.68%

Last updated:

Net Change in Cash of Qualtec Co is 2026 910.89 M JPY. Net Change in Cash of Qualtec Co was 2025 -367.77 M JPY. It decreases by -347.68% higher compared to the previous year.

The Qualtec Co Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2021
-71.55 M JPY
Jan 1, 2022
197.81 M JPY
Jan 1, 2023
-148.79 M JPY
Jan 1, 2024
639.26 M JPY
Jan 1, 2025
-367.77 M JPY
Jan 1, 2026
910.89 M JPY
The Qualtec Co Net Change in Cash history
YEARNet Change in CashYoY
910.89 MJPY-347.68%
-367.77 MJPY-157.53%
639.26 MJPY-529.63%
-148.79 MJPY-175.22%
197.81 MJPY-376.47%
-71.55 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Qualtec Co Stock analysis

What does Qualtec Co do? Qualtec Co Ltd generates revenue through three business segments. The Reliability Evaluation Business segment sells testing machines and provides environmental, electrical, and vibration tests, including non-defective and defective product analysis. The Microfabrication Business segment offers laser processing services for build-up boards and flexible printed boards in both prototype and mass production. The Other Business segment delivers genetic mutation detection services for pets, contracted biomedical testing for packaging materials and syringes, and zero innovation consulting services. These services target industrial clients, veterinary clinics, and biomedical companies. The company's Reliability Evaluation segment serves manufacturers requiring product reliability validation. The Microfabrication segment caters to electronics manufacturers needing laser processing for circuit boards. The genetic testing services in the Other Business segment are sold to pet owners and veterinary clinics. Biomedical testing services target companies in the medical device industry. Zero innovation consulting is offered to businesses seeking technology and surface treatment solutions. Qualtec's product portfolio includes testing machines, laser processing services, genetic mutation detection, biomedical testing, and consulting services. The company's primary customers are electronics manufacturers, biomedical firms, veterinary clinics, and pet owners. These segments collectively serve industrial and healthcare markets with specialized technical services. Qualtec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Qualtec Co stock

Net Change in Cash of Qualtec Co is 910.89 M JPY in 2026.

Net Change in Cash of Qualtec Co changed from -367.77 M JPY to 910.89 M JPY, representing a -347.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Qualtec Co since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Qualtec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Qualtec Co

All Key Metrics — Qualtec Co